Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: Dr. Christopher Missling CEO Anavex Discussing current state of research into neurodegenerative disorders, such as Alzheimer's disease and Parkinson’s, and Anavex’s approach with ANAVEX 2-73. Caroline Hyde of Bloomberg Television also participates in the conversation.